Raising the bar in liver cancer therapypharmaphorum interviews professor Jeff Evans, from the University of Glasgow’s Institute of Cancer Sciences, about findings of a Share XRaising the bar in liver cancer therapyhttps://pharmaphorum.com/oncology/insights-oncology/raising-bar-liver-cancer-therapy/
Eisai’s EMEA CEO Gary Hendler on why quality of life is key to Lenvima’s successGary Hendler, chairman and CEO of EMEA region for Eisai, talked to Richard Staines at pharmaphorum about findings Share XEisai’s EMEA CEO Gary Hendler on why quality of life is key to Lenvima’s successhttps://pharmaphorum.com/oncology/insights-oncology/eisais-emea-ceo-gary-hendler-lenvimas-success/
NeoAg Summit 2018 one-stop shop of information for advancing your NeoAg Share XNeoAg Summit 2018https://pharmaphorum.com/events/neoag-summit-2018/
From promise to practice: immuno-oncology in action – the new frontier in cancer treatmentImmuno-oncology therapies that harness the body’s own defences to fight off tumours are widely acknowledged as the new Share XFrom promise to practice: immuno-oncology in action – the new frontier in cancer treatmenthttps://pharmaphorum.com/whitepapers/from-promise-to-practice-immuno-oncology-in-action-the-new-frontier-in-cancer-treatment/
Round table transcript: Oncology shaping the future of personalised healthcareEarlier this year pharmaphorum filmed a round table debate exploring how developments in personalised healthcare cancer treatments are Share XRound table transcript: Oncology shaping the future of personalised healthcarehttps://pharmaphorum.com/whitepapers/round-table-transcript-oncology-shaping-the-future-of-personalised-healthcare/